| This article is a follow up from our earlier article on the vaccination of children 5-11 years old with the Pfizer vaccine.Since we do not have a risk-benefit analysis for Covid-19 vaccination in children 5-11 years old, it is best to refer to theThis was unanimously passed by the FDA panel, without opposition or abstentions. Similarly, it was evaluated by the Advisory Committee on Immunization Practices and unanimously recommended by all in the panel without exception.c.
Notwithstanding, even under this Scenario 3, considering the different implications and length of stay for Covid-19 hospitalisation versus hospitalisation for vaccine-associated myocarditis/pericarditis , and the benefits accrued from the prevention of cases of Covid-19 with significant morbidity, the overall benefits of the vaccine may still outweigh the risks.
The underlying epidemiology of viral myocarditis is substantially lower in younger children compared to children aged 12 years and older. It is anticipated that the rates of myocarditis/pericarditis after vaccination in 5-11-year-olds is most likely lower than the rates quoted in the risk-benefit analysis
This risk assessment neither considers potential long-term adverse effects due to Long-Covid, nor does it include secondary benefits like reducing Covid-19 transmission.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: UMonline - 🏆 27. / 51 Read more »
Source: msianinsight - 🏆 8. / 63 Read more »
Source: msianinsight - 🏆 8. / 63 Read more »
Source: msianinsight - 🏆 8. / 63 Read more »
Source: msianinsight - 🏆 8. / 63 Read more »
Source: NST_Online - 🏆 17. / 53 Read more »